Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Sustainability Reports

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. researches, develops, manufactures, and sells diagnostic and therapeutic products for allergic diseases. Its primary product portfolio focuses on sublingual immunotherapy treatments and allergen skin prick test diagnostic kits.

Sector: Manufacturing

Country: China

Exchange: Shenzhen Stock Exchange

LEI: 3003000DMXTOIP2M8505

FIGI: BBG002YW6BC3

5 reports from 2020 to 2024

• Zhejiang Wolwo Bio-Pharmaceutical Co Ltd 2024 Annual Report
• Zhejiang Wolwo Bio-Pharmaceutical Co Ltd 2023 Social Responsibility Report
• Zhejiang Wolwo Bio-Pharmaceutical Co Ltd 2022 Annual Report
• Zhejiang Wolwo Bio-Pharmaceutical Co Ltd 2021 Annual Report
• Zhejiang Wolwo Bio-Pharmaceutical Co Ltd 2020 Social Responsibility Report